When monocytes were incubated with A2A or A3AR agonists the production of MMP-1 was inhibited in RA patients more than in healthy subjects (60% or 49% in ERA, 58% or 49% in RA patients, 37% or 29% in healthy subjects, respectively) (Figure 3E). The gene discussed is MMP1; the disease is rheumatoid arthritis.